01-04-2003 | Original Article
Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers
Published in: Cancer Immunology, Immunotherapy | Issue 4/2003
Login to get access01-04-2003 | Original Article
Published in: Cancer Immunology, Immunotherapy | Issue 4/2003
Login to get access